Search
-
How new obesity medications could transform the grocery landscape
Anti-obesity medications’ influence on Americans’ personal habits and diets could have cascading effects for food and beverage retailers, according to a new Ipsos study. Ipsos’ Rhoda Schmuecking explains.
-
[WEBINAR] What the Future: Parenting
What the Future: Parenting offers exclusive data and analysis on what today’s (and tomorrow’s) parents want, and how business leaders and policymakers can support them today and in the coming years.
-
Parenting
It’s said that parents have the hardest job in the world — and that job comes with plenty of hopes, fears, and unmet needs that brands can help solve.
-
So Much to Lose: Changing landscape of obesity in America
Revisit our recorded webinar exploring obesity, weight loss, and the broader implications for sectors from healthcare to food and beverage.
-
Monitoring the obesity treatment revolution, in healthcare and beyond
Ipsos has launched three new syndicated studies to monitor and anticipate changes in the rapidly evolving landscape of obesity treatment.
-
[WEBINAR] So Much to Lose: Changing landscape of obesity in America
Would you take a medication that would help you lose weight? Join us on December 13 as we deep dive into the implications of new obesity treatments.
-
Half of Americans would be interested in a weight loss medication
More than half of Americans would be interested in taking a new 'safe and effective' weight loss treatment, according to new data from the Ipsos Consumer Tracker
-
The future of health and nutrition – Tetra Pak Index 2023
The 2023 Tetra Pak Index, conducted in partnership with Ipsos, explores how the global pandemic has shifted consumer focus towards health and sustainability, and the role of technology in shaping the future of food and beverage.
-
Ipsos and its clients honored with 13 wins at the 2023 ARF Ogilvy Awards
Multiple campaigns shaped by Ipsos research have been recognized by the Advertising Research Foundation